Dermira, Inc.

Dermira, Inc.

Dermira, Inc.

Dermira is a development-stage biotech company focused on developing andcommercializing innovative new therapies in dermatology.
Founded
2010
Raised
$129.5M
Follow us
Alexa global traffic share
Acquired by
Eli Lilly and Co
2
10 Jan 2020
Latest funding Show all
$1,500,000
Post-IPO equity - 2016
$51,000,000
Venture capital (Series C) - 2014
Canaan Partners Aisling Capital NEA +5
Acquisition
Xconomy , FinSMEs

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Bloomberg

Dermira Reminds Investors What Binary Means in Biotech

Stock markets Health
Xconomy

Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters

Health
Xconomy

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Health